John M Climaco is Chief Executive Officer of CNS Pharmaceuticals, Inc.. Currently has a direct ownership of 215,676 shares of CNSP, which is worth approximately $23,724. The most recent transaction as insider was on Feb 01, 2024, when has been sold 166,666 shares (Common Stock) at a price of $0.3 per share, resulting in proceeds of $49,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 216K
0% 3M change
340.07% 12M change
Total Value Held $23,724

John M Climaco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
BUY
Open market or private purchase
$49,999 $0.3 p/Share
166,666 Added 43.59%
215,676 Common Stock
Aug 16 2023
BUY
Open market or private purchase
$4,950 $1.8 p/Share
2,750 Added 5.31%
49,010 Common Stock
Apr 28 2023
BUY
Exercise of conversion of derivative security
-
1,250 Added 2.63%
46,260 Common Stock
Apr 12 2023
BUY
Open market or private purchase
$10,350 $0.69 p/Share
15,000 Added 25.0%
45,010 Common Stock
Mar 07 2022
BUY
Grant, award, or other acquisition
$9,800 $0.28 p/Share
35,000 Added 3.59%
940,298 Common Stock
Nov 16 2021
BUY
Grant, award, or other acquisition
$6,400 $1.28 p/Share
5,000 Added 0.55%
905,298 Common Stock

Also insider at

MBRX
Moleculin Biotech, Inc. Healthcare
JMC

John M Climaco

Chief Executive Officer
Houston, TX

Track Institutional and Insider Activities on CNSP

Follow CNS Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNSP shares.

Notify only if

Insider Trading

Get notified when an Cns Pharmaceuticals, Inc. insider buys or sells CNSP shares.

Notify only if

News

Receive news related to CNS Pharmaceuticals, Inc.

Track Activities on CNSP